2023 Conference Archive: Speakers

Click on the sessions below to be taken directly to their presentation slides

Session 1 :: Andrew Roddam
RWE and the Global Research Landscape

Opening Keynote :: Catherine Cohet
RWE and the Changing EU Landscape

Opening Keynote :: Marcus Guardian
Real World Evidence and the Changing EU Landscape

Session 3 :: Gracy Crane
Increasing Use of Real World Evidence in Asia

Session 3 :: Hu Suk Kwan
Increasing Use of Real World Evidence in Malaysia

Session 4 :: Donna Rivera
How Do US Stakeholders Use Real World Evidence For a Better Understanding of Value

Session 4 :: Irene Nunes
How Do US Stakeholders Use Real World Evidence For a Better Understanding of Value

Session 4 :: Darren Toh
How Do US Stakeholders Use Real World Evidence For a Better Understanding of Value

Session 5 :: Sebastian Garcia Marti
Experiences and Challenges of Using Real World Evidence for Decision Making in Latin America

Session 5 :: Lizbeth Acuña
Experiences and Challenges of Using Real World Evidence for Decision Making in Latin America

Session 5 :: Otavio Berwanger
Experiences and Challenges of Using Real World Evidence for Decision Making in Latin America

Breakout Session 1 :: Bettina Ryll
The Patient Value of Real World Evidence

Breakout Session 1 :: Hayley Chapman
Patient Focused Medicines Development

Breakout Session 1 :: Elizabeth Vroom
World Duchenne Organization

Breakout Session 2 :: Marieke S. Jansen
Pivotal Evidence

Breakout Session 2 :: Wim Goettsch
External Comparators

Breakout Session 3 :: Nigel Hughes
EHDEN (European Health Data & Evidence Network)

Breakout Session 3 :: Mira Zuidgeest
Trials@Home

Breakout Session 3 :: Peter R. Rijnbeek
Darwin EU

Closing Keynote Address :: Mark B. McClellan
Advancing Real-World Data and Evidence in Global Contexts

Session 1 :: Andrew Roddam :: Real World Evidence and the Global Research Landscape
Opening Keynote :: Catherine Cohet :: Real World Evidence and the Changing EU Landscape
Opening Keynote :: Marcus Guardian :: Real World Evidence and the Changing EU Landscapee
Session 3 :: Gracy Crane :: Increasing Use of Real World Evidence in Asia
Session 3 :: Hu Suk Kwan :: Increasing Use of Real World Evidence in Malaysia
Session 4 :: Donna Rivera :: How Do US Stakeholders Use Real World Evidence For a Better Understanding of Value
Session 4 :: Irene Nunes :: How Do US Stakeholders Use Real World Evidence For a Better Understanding of Value
Session 4 :: Darren Toh :: How Do US Stakeholders Use Real World Evidence For a Better Understanding of Value
Session 5 :: Sebastian Garcia Marti :: Experiences and Challenges of Using Real World Evidence for Decision Making in Latin America
Session 5 :: Lizbeth Acuña :: Experiences and Challenges of Using Real World Evidence for Decision Making in Latin America
Session 5 :: Otavio Berwanger :: Experiences and Challenges of Using Real World Evidence for Decision Making in Latin America
Breakout Session 1 :: Bettina Ryll :: The Patient Value of Real World Evidence
Breakout Session 1 :: Hayley Chapman :: Patient Focused Medicines Development
Breakout Session 1 :: Elizabeth Vroom :: World Duchenne Organization
Breakout Session 2 :: Marieke S. Jansen :: Pivotal Evidence
Breakout Session 2 :: Wim Goettsch :: External Comparators
Breakout Session 3 :: Nigel Hughes :: EHDEN (European Health Data & Evidence Network)
Breakout Session 3 :: Mira Zuidgeest :: Trials@Home
Breakout Session 3 :: Peter R. Rijnbeek :: Darwin EU
Closing Keynote Address :: Mark B. McClellan :: Advancing Real-World Data and Evidence in Global Contexts
Scroll to Top